Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Dipharma-SA, commercially known as Dipharma Francis S.r.l., is a leading European Contract Development and Manufacturing Organization (CDMO) and a global provider of high-quality Active Pharmaceutical Ingredients (APIs). With a strong focus on innovation, cGMP compliance, and customer service, Dipharma supports pharmaceutical companies worldwide from preclinical development through commercial supply. They specialize in both generic and proprietary APIs, leveraging advanced chemical synthesis, process development expertise, and a robust quality system. Their portfolio includes custom synthesis for exclusive and non-exclusive APIs, particularly in areas like high-potency APIs (HPAPIs) and orphan drugs.
Serves as the central hub for strategic decision-making, global sales, research and development coordination, quality assurance oversight, and administrative operations for the entire Dipharma group.
The Baranzate site likely houses advanced R&D laboratories, pilot plant facilities for process development and small-scale cGMP manufacturing, and modern administrative offices. It's equipped to handle complex chemical processes and analytical development.
The work culture is expected to be highly professional, science-driven, and quality-focused, emphasizing collaboration, innovation, and adherence to stringent pharmaceutical industry standards (cGMP). Employees likely experience a dynamic environment dedicated to solving complex scientific challenges.
Its location in the Milan metropolitan area provides excellent access to a skilled workforce, research institutions, logistical networks, and a strong pharmaceutical ecosystem, facilitating global operations and partnerships.
Dipharma-SA operates with a global footprint, supporting pharmaceutical clients worldwide. Its core functions, including API research and development, cGMP manufacturing, custom synthesis, quality control/assurance, and regulatory support, are primarily centered in its Italian manufacturing sites and R&D facilities. These are complemented by its US subsidiary (Dipharma Inc. and Dipharma Tech USA) which provides sales, marketing, local project management, and US-based manufacturing capabilities. Dipharma serves markets across Europe, North America, Asia, and other international regions, exporting its APIs globally.
Via Bissone, 5
Baranzate
MI (Milan)
Italy
Address: Via Moimacco Altaneto, 15, 33036 Mereto di Tomba (UD), Italy
Contributes significantly to Dipharma's overall API production capacity and expertise, particularly for complex syntheses and large volume requirements, serving European and international clients.
Address: Via XXV Aprile, 178, 21042 Caronno Pertusella (VA), Italy
Enhances Dipharma's manufacturing flexibility and capability to produce a wide range of APIs, ensuring robust supply chain solutions for pharmaceutical partners.
Address: Dipharma Inc., 10 Polito Avenue, Suite 205, Lyndhurst, NJ 07071, USA
To strengthen Dipharma's presence in the critical North American pharmaceutical market, providing localized support and fostering direct partnerships with American clients.
Address: Dipharma Tech USA, 4000 Portage Street, Kalamazoo, MI 49001, USA
To offer US-based clients domestic API development and manufacturing solutions, reducing logistical complexities and enhancing responsiveness for early-phase projects and specialized APIs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Dipharma SA' leadership includes:
Dipharma SA has been backed by several prominent investors over the years, including:
Based on publicly available information, Dipharma-SA has maintained a relatively stable core executive team. No major high-profile executive hires or departures have been broadly announced in the last 12 months, suggesting continuity in leadership.
Discover the tools Dipharma SA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Dipharma-SA (Dipharma Francis S.r.l.) most commonly uses the email format combining the first initial and last name, or first name dot last name, followed by '@dipharma.com'.
[first_initial][last]@dipharma.com or [first].[last]@dipharma.com
Format
jdoe@dipharma.com or jane.doe@dipharma.com
Example
85%
Success rate
PR Newswire • October 17, 2023
Dipharma Francis S.r.l. announced a significant expansion of its cGMP manufacturing capabilities at its American subsidiary, Dipharma Inc. (now operating as Dipharma Tech USA for this facility), located in Kalamazoo, Michigan. This expansion includes new kilolab areas and aims to enhance services for US-based customers, particularly for clinical trial materials and niche commercial APIs....more
Dipharma Official Website / CPHI Online • February 7, 2023
Dipharma Francis S.r.l. and Carbogen Amcis AG (a Dishman Carbogen Amcis Ltd company) have entered into a strategic partnership to provide an integrated, seamless offering for the process development and cGMP manufacturing of peptides and oligonucleotides, from preclinical to commercial stages. This collaboration leverages the complementary expertise of both companies....more
Dipharma Official Website • September 20, 2022
Dipharma Francis S.r.l. announced it received authorization from the Italian Medicines Agency (AIFA) to manufacture Active Pharmaceutical Ingredients (APIs) for clinical trials at its R&D facility in Baranzate (Milan), Italy. This new cGMP Kilo Lab will enhance the company's capacity to support early-stage development projects....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Dipharma SA, are just a search away.